Controlling monoclonal antibody aggregation during cell culture using medium additives facilitated by the monitoring of aggregation in cell culture matrix using size exclusion chromatography-Reference-Cited by-同舟云学术

Controlling monoclonal antibody aggregation during cell culture using medium additives facilitated by the monitoring of aggregation in cell culture matrix using size exclusion chromatography

Published:2023-09 Issue: Volume:234 Page:115575
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Kumari Prity,Saldanha Marianne,Jain Ratnesh,Dandekar Prajakta^ORCID

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference42 articles.

1. Recombinant therapeutic protein production in cultivated mammalian cells: current status and future prospects;Matasci;Drug Discov. Today Technol.,2008

2. High-yield production of “difficult-to-express” proteins in a continuous exchange cell-free system based on CHO cell lysates;Thoring;Sci. Rep.,2017

3. Monoclonal antibodies: versatile platforms for cancer immunotherapy;Weiner;Nat. Rev. Immunol.,2010

4. Monoclonal antibody therapeutics: history and future;Buss;Curr. Opin. Pharm.,2012

5. Trends in upstream and downstream process development for antibody manufacturing;Gronemeyer;Bioengineering,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An integrated methodology for quality assessment of therapeutic antibodies with potential long circulation half-life in harvested cell culture fluid using FcRn immobilized hydrophilic magnetic graphene;Talanta;2024-05

2. Single-use biosensors for biomanufacturing: Perspective on the state-of-the-art;Current Opinion in Biomedical Engineering;2023-12